...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote Reminder

Hi folks.

The AGM is getting close but there is still time to express your "withhold" position or "for" if you actually believe this board of directors has done their job of creating shareholder value by appointing the most competent and effective CEO.

Remember it was your investment money that went into the formation of Zenith Epigenetics and has been locked away for 10 years with only OTC liquidity.

Anyway, it is always fun to watch our ersatz scientist "Mr Excitment" talk trials and science and steel the thunder of his business and science teams achievements with 98% of the time dedicated to these wonderful and promising trials. Why not share the stage and feature one of the scientists and also have Dr Lakhotia address the business issues, challenges and hopes.

The 2% of the time spent on business will be something like the following;

  • we're in negotiations with big partners but it is too soon to talk about them at this stage.
  • just imagine with zen3694 enhancing so many drugs how big the market will be.

Always a good 20 minutes of BS and fun. There might even be a staged question or 2.  :)

GLTA

Toinv

 

Share
New Message
Please login to post a reply